Why Myriad Genetics (MYGN) Shares Are Falling Today
Shares of genetic testing company Myriad Genetics (NASDAQ:MYGN) fell 3.8% in the afternoon session after weakness in the…
Novel AI application diagnoses endocrine cancers with speed and accuracy
A novel artificial intelligence (AI) application capable of diagnosing endocrine cancers with speed and accuracy is being presented…